PEPTIMIMESIS
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of peptidomimetic candidates interfering with the hetero- and/or the homodimerization of target receptors. PeptiMimesis will develop its pipeline against key targets in the fields of oncology, immuno-oncology and immune disease and is open to initiate collaboration with pharma partners on receptors of interest.
PEPTIMIMESIS
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2015-10-01
Address:
Illkirch, Alsace, France
Country:
France
Website Url:
http://www.peptimimesis.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.15 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Apache
Similar Organizations
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Versameb
Versameb is focusing on the discovery and development of innovative, next-generation RNA-based drugs.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cap Innov'Est
Cap Innov'Est investment in Seed Round - PeptiMimesis
Cap Innov'Est
Cap Innov'Est investment in Seed Round - PeptiMimesis
More informations about "PeptiMimesis"
PeptiMimesis
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of …See details»
PeptiMimesis - Crunchbase Company Profile & Funding
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides.See details»
PeptiMimesis Company Profile 2024: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for PeptiMimesis. Use the PitchBook Platform to explore the full profile.See details»
PeptiMimesis - VentureRadar
"PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of …See details»
PeptiMimesis - Contacts, Employees, Board Members, Advisors
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides.See details»
PeptiMimesis - Craft
PeptiMimesis $2.14 m in total funding,. See insights on PeptiMimesis including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Domain Therapeutics 160229 PeptiMimesis EN
“The creation of PeptiMimesis is the culmination of many years of work developing our technology,” said Dr Dominique Bagnard, founder. “With my two long-standing collaborators …See details»
PeptiMimesis: New biotech startup developing next generation ...
Feb 29, 2016 PeptiMimesis was founded by three academic researchers, each having more than 15 years of experience in the field of transmembrane peptides, and Domain Therapeutics, a …See details»
Domain Therapeutics 160229 PeptiMimesis EN
PeptiMimesis was founded by three academic researchers, each having more than 15 years of experience in the field of transmembrane peptides, and Domain Therapeutics, a drug …See details»
PeptiMimesis 160420 Fundraising EN MS FINAL CLEAN
“PeptiMimesis is a very promising start-up company in the Cap Innov’Est portfolio,” said Jean-François Rax, investment director at Cap Innov’Est. "It has a highly experienced team, …See details»
PeptiMimesis - Overview, News & Competitors | ZoomInfo.com
View PeptiMimesis (www.peptimimesis.com) location in Wallis and Futuna, France , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
PeptiMimesis - Funding, Financials, Valuation & Investors
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides.See details»
PeptiMimesis – Funding, Valuation, Investors, News | Parsers VC
Information about PeptiMimesis is updated every day. PeptiMimesis valuation, number of raised finances, contact details, names of founders, latest news.See details»
PeptiMimesis | VentureRadar
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides. Our innovative approach enables the identification of …See details»
Peptimimesis SAS: Drug pipelines, Patents, Clinical trials - Synapse
Jul 5, 2023 Explore Peptimimesis SAS with its drug pipeline, therapeutic area, technology platform, 3 news.See details»
PeptiMimesis - Scrip
PeptiMimesis is developing first-in-class transmembrane therapeutic peptides with potential in immuno-oncology, oncology and immune diseases. Its technology is based on research …See details»
PeptiMimesis - News, Articles, Whitepapers - Drug Target Review
PeptiMimesis is a new biotech startup developing a novel class of therapeutic peptides using a breakthrough technology...See details»
PeptiMimesis - Tech Stack, Apps, Patents & Trademarks
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides.See details»
PeptiMimesis 170315 Fundraising EN FINAL
About PeptiMimesis Created in October 2015, PeptiMimesis is a biopharmaceutical company based in Strasbourg, France, dedicated to the discovery and development of transmembrane …See details»
PeptiMimesis - Crunchbase
PeptiMimesis is a strategic partner in the design, the discovery and the early development of transmembrane therapeutic peptides.See details»